Clinical phenotype and infertility treatment in a male with hypogonadotropic hypogonadism due to mutations Ala129Asp/Arg262Gln of the gonadotropin-releasing hormone receptor

Lawrence C Layman, David P. Cohen, Jun Xie, Gary D. Smith

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Objective: To characterize the genotype and phenotype of a man with idiopathic hypogonadism with infertility. Design: Molecular analysis and clinical description. Setting: Medical school laboratory and reproductive endocrine clinic. Patient(s): A 40-year-old male with idiopathic hypogonadotropic hypogonadism. Intervention(s): Denaturing gradient gel electrophoresis analysis and DNA sequencing of the gonadotropin-releasing hormone receptor (GNRHR) gene were performed. The patient was treated with hCG and FSH. Main Outcome Measure(s): GNRHR mutation detection, genotype/phenotype correlation, and testicular response to exogenous gonadotropin therapy. Result(s): The proband demonstrated compound heterozygosity for Ala129Asp/Arg262Gln GNRHR mutations. He had a complete form of idiopathic hypogonadotropic hypogonadism, with descended testes and severe oligospermia but little response to exogenous gonadotropins. Conclusion(s): The phenotype of this patient differs from the one other family described with the same mutations. Exogenous gonadotropin therapy may not be as beneficial for increasing sperm concentration in older men with idiopathic hypogonadotropic hypogonadism.

Original languageEnglish (US)
Pages (from-to)1317-1320
Number of pages4
JournalFertility and sterility
Volume78
Issue number6
DOIs
StatePublished - Dec 1 2002

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Clinical phenotype and infertility treatment in a male with hypogonadotropic hypogonadism due to mutations Ala129Asp/Arg262Gln of the gonadotropin-releasing hormone receptor'. Together they form a unique fingerprint.

  • Cite this